Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Professor in Population Health Sciences
Core Faculty in Innovation & Entrepreneurship
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address scott.palmer@duke.edu

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993

Grants

Publications

Mariencheck, William I., John F. Alcorn, Scott M. Palmer, and Jo Rae Wright. “Pseudomonas aeruginosa elastase degrades surfactant proteins A and D..” Am J Respir Cell Mol Biol 28, no. 4 (April 2003): 528–37. https://doi.org/10.1165/rcmb.2002-0141OC.

PMID
12654643
Full Text

Choi, Yo Won, Santiago E. Rossi, Scott M. Palmer, David DeLong, Jeremy J. Erasmus, and H Page McAdams. “Bronchiolitis obliterans syndrome in lung transplant recipients: correlation of computed tomography findings with bronchiolitis obliterans syndrome stage..” J Thorac Imaging 18, no. 2 (April 2003): 72–79. https://doi.org/10.1097/00005382-200304000-00003.

PMID
12700480
Full Text

Davis, R Duane, Christine L. Lau, Steve Eubanks, Robert H. Messier, Denis Hadjiliadis, Mark P. Steele, and Scott M. Palmer. “Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation..” J Thorac Cardiovasc Surg 125, no. 3 (March 2003): 533–42. https://doi.org/10.1067/mtc.2003.166.

PMID
12658195
Full Text

Patel, Vijay S., Scott M. Palmer, Robert H. Messier, and R Duane Davis. “Clinical outcome after coronary artery revascularization and lung transplantation..” Ann Thorac Surg 75, no. 2 (February 2003): 372–77. https://doi.org/10.1016/s0003-4975(02)04639-8.

PMID
12607642
Full Text

Palmer, S. M., S. Garantziotis, and N. L. Reinsmoen. “Clinical significance of anti human leukocyte antigen antibodies in lung transplantation.” Current Opinion in Organ Transplantation 8, no. 3 (January 1, 2003): 217–21. https://doi.org/10.1097/00075200-200309000-00001.

Full Text

Zaas, David, and Scott M. Palmer. “Respiratory failure early after lung transplantation: now that we know the extent of the problem, what are the solutions?.” Chest 123, no. 1 (January 2003): 14–16. https://doi.org/10.1378/chest.123.1.14.

PMID
12527595
Full Text

Lau, C. L., S. M. Palmer, D. N. Howell, R. McMahon, D. Hadjiliadis, J. Gaca, T. N. Pappas, R. D. Davis, and S. Eubanks. “Laparoscopic antireflux surgery in the lung transplant population..” Surg Endosc 16, no. 12 (December 2002): 1674–78. https://doi.org/10.1007/s00464-001-8251-2.

PMID
12140642
Full Text

Hadjiliadis, Denis, Robert D. Davis, and Scott M. Palmer. “Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?.” Chest 122, no. 4 (October 2002): 1168–75. https://doi.org/10.1378/chest.122.4.1168.

PMID
12377838
Full Text

Napolitano, Melissa A., Michael A. Babyak, Scott Palmer, Victor Tapson, R Duane Davis, James A. Blumenthal, and James A. Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE) Investigators. “Effects of a telephone-based psychosocial intervention for patients awaiting lung transplantation..” Chest 122, no. 4 (October 2002): 1176–84. https://doi.org/10.1378/chest.122.4.1176.

PMID
12377839
Full Text

Reams, B Diane, R Duane Davis, Julia Curl, and Scott M. Palmer. “Treatment of refractory acute rejection in a lung transplant recipient with campath 1H..” Transplantation 74, no. 6 (September 27, 2002): 903–4. https://doi.org/10.1097/00007890-200209270-00034.

PMID
12364881
Full Text

Pages